The next pharmaceutical innovation could be the one that makes it possible to produce existing molecules with less resources, says Claude Grison, research director at the CNRS, guest professor at the Collège de France, and member of the Académie des Sciences
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The next pharmaceutical innovation could be the one that makes it possible to produce existing molecules with less resources, says Claude Grison, research director at the CNRS, guest professor at the Collège de France, and member of the Académie des Sciences